References
- Whitehurst AW, Xie Y, Purinton SC, Cappell KM, Swanik JT, Larson B, et al. Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation. Cancer Res. 2010; 70:7652–61.
- Stamm S, Smith C, Lührmann R, editors. Alternative pre-mRNA splicing: theory and protocols. Weinheim, Germany: Wiley-VCH Verlag; 2012.
- Hemminger JA, Toland AE, Scharschmidt TJ, Mayerson JL, Guttridge DC, Iwenofu OH. Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma. Mod Pathol. 2014; 27:1238–45.
- Luo B, Yun X, Lin YD, Xiao SW, Yan GH, He SJ, et al. [Construction of eukaryotic expression vector encoding ACRBP and its expression in hepatocarcinoma cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi [Chinese Journal of Cellular and Molecular Immunology]. 2011; 27:1072–4. [in Chinese, English abstract].
- Luo B, Yun X, Fan R, Lin Y-D, He S-J, Zhang Q-M, et al. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters. Int J Clin Exp Pathol. 2013; 6:2835–45.
- Li X, Yan J, Fan R, Luo B, Zhang Q, Lin Y, et al. Serum immunore-activity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma. Oncol Lett. 2017; 13:3080–6.
- Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci U S A. 2001; 98:3282–7.
- Kazemi-Oula G, Ghafouri-Fard S, Mobasheri MB, Geranpayeh L, Modarressi MH. Upregulation of RHOXF2 and ODF4 expression in breast cancer tissues. Cell J. 2015; 17:471–7.
- Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017; 18:437–51.
- Zheng B. Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors. Asian Biomed (Research Review News). 2020: 14(6);243–52.
- Urbanski LM, Leclair N, Anczuków O. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018; 9:e1476. doi: 10.1002/wrna.1476